Back
Keros Therapeutics Stock Price Chart
Sponsored
KROS
Sponsored
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge
Sell
39
KROS
Keros Therapeutics
Last Price:
58.34
Seasonality Move:
-4.32%
7 Day Trial
ALL ACCESS PASS
$
7
NOW is the time to get in on this trillion-dollar megatrend
Get it here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.
Keros Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.24 | Sell |
20-day SMA: | 62.47 | Sell |
50-day SMA: | 63.41 | Sell |
200-day SMA: | 43.93 | Buy |
8-day EMA: | 59.56 | Sell |
20-day EMA: | 61.56 | Sell |
50-day EMA: | 60.78 | Sell |
200-day EMA: | 49.53 | Buy |
Keros Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.56 | Sell |
Relative Strength Index (14 RSI): | 39.95 | Sell |
Chaikin Money Flow: | 64919 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (59.99 - 66.47) | Sell |
Bollinger Bands (100): | (40.86 - 66.12) | Buy |
Keros Therapeutics Technical Analysis
Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 58.44 while KROS 8-day simple moving average is 59.24, which is a Sell signal.
- The stock price of KROS is 58.44 while Keros Therapeutics 20-day SMA is 62.47, which makes it a Sell.
- Keros Therapeutics 50-day simple moving average is 63.41 while KROS share price is 58.44, making it a Sell technically.
- KROS stock price is 58.44 and Keros Therapeutics 200-day simple moving average is 43.93, creating a Buy signal.
KROS Technical Analysis vs Fundamental Analysis
Sell
39
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a Sell
The current Keros Therapeutics [KROS] share price is $58.44. The Score for KROS is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Keros Therapeutics Stock Info
Market Cap:
2.1B
Price in USD:
58.44
Share Volume:
293.31K
Keros Therapeutics 52-Week Range
52-Week High:
73.00
52-Week Low:
27.02
Sell
39
Keros Therapeutics (KROS)
is a Sell
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?
The Keros Therapeutics stock price is 58.44 USD today. -
Will KROS stock go up or go down?
Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Keros Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is overvalued.
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 58.44 while KROS 8-day exponential moving average is 59.56, which is a Sell signal.
- The stock price of KROS is 58.44 while Keros Therapeutics 20-day EMA is 61.56, which makes it a Sell.
- Keros Therapeutics 50-day exponential moving average is 60.78 while KROS share price is 58.44, making it a Sell technically.
- KROS stock price is 58.44 and Keros Therapeutics 200-day simple moving average is 49.53, creating a Buy signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.20 per share, an increase this year of $0.03 per share, and a decrease next year of $0.37 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
- KROS Moving Average Covergence Divergence (MACD) indicator is -1.56, suggesting Keros Therapeutics is a Sell
- Keros Therapeutics Relative Strength Index (RSI) is 39.95, which suggest Keros Therapeutics is oversold
- The Bollinger Bands (25) for Keros Therapeutics is (59.99 - 66.47), which suggest Keros Therapeutics is a Buy
- The Bollinger Bands (100) for Keros Therapeutics is (40.86 - 66.12), which suggest Keros Therapeutics is a Buy
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.